TBPH icon

Theravance Biopharma

119 hedge funds and large institutions have $546M invested in Theravance Biopharma in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 49 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

4.37% less ownership

Funds ownership: 95.69%91.32% (-4.4%)

16% less capital invested

Capital invested by funds: $653M → $546M (-$106M)

41% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 49

Holders
119
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$431K
Puts
$299K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$77.2M
2
$76.8M
3
$72.6M
4
$52.6M
5
$43.7M
6
$28.6M
7
$19.1M
8
$17.8M
9
$17M
10
$15.3M
11
$12.1M
12
$9.99M
13
$7.39M
14
$6.69M
15
$6.39M
16
$6.18M
17
$5.63M
18
$5.02M
19
$4.67M
20
$4.41M
21
$4.18M
22
$3.53M
23
$3.12M
24
$3.1M
25
$2.97M